HomeCompareSYK vs KLAC

SYK vs KLAC: Dividend Comparison 2026

SYK yields 1.04% · KLAC yields 0.55%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KLAC wins by $751.9K in total portfolio value· pulled ahead in Year 3
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
KLAC
KLAC
● Live price
0.55%
Share price
$1,382.58
Annual div
$7.60
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$795.3K
Annual income
$589,306.66
Full KLAC calculator →

Portfolio growth — SYK vs KLAC

📍 KLAC pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKKLAC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + KLAC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
KLAC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
KLAC
Annual income on $10K today (after 15% tax)
$46.72/yr
After 10yr DRIP, annual income (after tax)
$500,910.66/yr
At 15% tax rate, KLAC beats the other by $493,870.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + KLAC for your $10,000?

SYK: 50%KLAC: 50%
100% KLAC50/50100% SYK
Portfolio after 10yr
$419.3K
Annual income
$298,794.82/yr
Blended yield
71.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
KLAC
Analyst Ratings
27
Buy
14
Hold
2
Sell
Consensus: Buy
Price Target
$1,696.31
+22.7% upside vs current
Range: $1,400.00 — $1,900.00
Altman Z
12.3
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
KLAC buys
8
PoliticianChamberTickerTypeAmountDate
Val Hoyle🏢 House$KLAC▼ Sell$1,001 - $15,0002025-09-23
Valerie Hoyle🏢 House$KLAC▲ Buy$1,001 - $15,0002025-07-28
Valerie Hoyle🏢 House$KLAC▼ Sell$1,001 - $15,0002025-04-29
William R. Keating🏢 House$KLAC▲ Buy$1,001 - $15,0002025-01-24
Gilbert Cisneros🏢 House$KLAC▼ Sell$1,001 - $15,0002025-01-13
Valerie Hoyle🏢 House$KLAC▲ Buy$1,001 - $15,0002024-10-29
John James🏢 House$KLAC▼ Sell$1,001 - $15,0002024-09-04
John James🏢 House$KLAC▼ Sell$1,001 - $15,0002024-06-26
Tommy Tuberville🏛 Senate$KLAC▼ Sell$1,001 - $15,0002024-05-03
Ro Khanna🏢 House$KLAC▲ Buy$1,001 - $15,0002024-01-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKKLAC
Forward yield1.04%0.55%
Annual dividend / share$3.40$7.60
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%100%
Portfolio after 10y$43.3K$795.3K
Annual income after 10y$8,282.98$589,306.66
Total dividends collected$21.0K$757.1K
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusBuyBuy
Analyst price target$428.67$1,696.31

Year-by-year: SYK vs KLAC ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrKLAC PortfolioKLAC Income/yrGap
1$10,852$152.43$10,810$109.94+$42.00SYK
2$11,838$226.03$11,789$222.14+$49.00SYK
3← crossover$13,004$336.89$13,067$452.81$63.00KLAC
4$14,420$505.63$14,920$938.13$500.00KLAC
5$16,195$766.09$17,966$2,002.14$1.8KKLAC
6$18,504$1,175.64$23,730$4,506.49$5.2KKLAC
7$21,635$1,835.40$36,517$11,125.83$14.9KKLAC
8$26,082$2,932.10$71,075$32,001.78$45.0KKLAC
9$32,737$4,829.68$192,474$116,423.57$159.7KKLAC
10$43,312$8,282.98$795,254$589,306.66$751.9KKLAC

SYK vs KLAC: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

KLACTechnology

KLA Corporation designs, manufactures, and markets process control, process-enabling, and yield management solutions for the semiconductor and related electronics industries worldwide. It operates through four segments: Semiconductor Process Control; Specialty Semiconductor Process; PCB, Display and Component Inspection; and Other. The company offers integrated circuit (IC) manufacturing products that comprises wafer inspection and review, and metrology; wafer and substrate defect inspection and metrology; reticle defect inspection and metrology; chemical/materials quality analysis; in situ process management and wafer handling diagnostics for IC and original equipment manufacturer (OEM) manufacturing; software products to provide run-time process control, defect excursion identification, process corrections, and defect classification; and refurbished and remanufactured products. It also provides specialty semiconductor manufacturing, benchtop metrology, surface characterization, and electrical property measurement services for general purpose/ lab applications; etch, plasma dicing, deposition, and other wafer processing technologies and solutions for the semiconductor and microelectronics industry. In addition, the company offers direct imaging, inspection, optical shaping, additive printing, and computer-aided manufacturing and engineering solutions for the PCB market; inspection and electrical testing systems to identify and classify defects, as well as systems to repair defects for the display market; and inspection and metrology systems for quality control and yield improvement in advanced and traditional semiconductor packaging markets. The company was formerly known as KLA-Tencor Corporation and changed its name to KLA Corporation in July 2019. KLA Corporation was incorporated in 1975 and is headquartered in Milpitas, California.

Full KLAC Calculator →
📬

Get this SYK vs KLAC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.